262 related articles for article (PubMed ID: 25860797)
1. An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system.
Pietschmann S; von Bueren AO; Kerber MJ; Baumert BG; Kortmann RD; Müller K
PLoS One; 2015; 10(4):e0121592. PubMed ID: 25860797
[TBL] [Abstract][Full Text] [Related]
2. An individual patient data meta-analysis on characteristics, treatments and outcomes of the glioblastoma/gliosarcoma patients with central nervous system metastases reported in literature until 2013.
Pietschmann S; von Bueren AO; Henke G; Kerber MJ; Kortmann RD; Müller K
J Neurooncol; 2014 Dec; 120(3):451-7. PubMed ID: 25160993
[TBL] [Abstract][Full Text] [Related]
3. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
5. Secondary gliosarcoma with extra-cranial metastases: a report and review of the literature.
Dawar R; Fabiano AJ; Qiu J; Khushalani NI
Clin Neurol Neurosurg; 2013 Apr; 115(4):375-80. PubMed ID: 22795300
[TBL] [Abstract][Full Text] [Related]
6. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
7. Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature.
Anghileri E; Castiglione M; Nunziata R; Boffano C; Nazzi V; Acerbi F; Finocchiaro G; Eoli M
Neurosurg Rev; 2016 Jan; 39(1):37-45; discussion 45-6. PubMed ID: 26212701
[TBL] [Abstract][Full Text] [Related]
8. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015.
Beyer S; von Bueren AO; Klautke G; Guckenberger M; Kortmann RD; Pietschmann S; Müller K
PLoS One; 2016; 11(2):e0148312. PubMed ID: 26859136
[TBL] [Abstract][Full Text] [Related]
10. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.
Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T
Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210
[TBL] [Abstract][Full Text] [Related]
11. Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial.
Oehler C; Frei K; Rushing EJ; McSheehy PM; Weber D; Allegrini PR; Weniger D; Lütolf UM; Knuth A; Yonekawa Y; Barath K; Broggini-Tenzer A; Pruschy M; Hofer S
Oncology; 2012; 83(1):1-9. PubMed ID: 22688083
[TBL] [Abstract][Full Text] [Related]
12. Gliosarcoma: an audit from a single institution in India of 24 post-irradiated cases over 15 years.
Kumar P; Singh S; Kumar P; Krishnani N; Datta NR
J Cancer Res Ther; 2008; 4(4):164-8. PubMed ID: 19052388
[TBL] [Abstract][Full Text] [Related]
13. The natural history of extracranial metastasis from glioblastoma multiforme.
Lun M; Lok E; Gautam S; Wu E; Wong ET
J Neurooncol; 2011 Nov; 105(2):261-73. PubMed ID: 21512826
[TBL] [Abstract][Full Text] [Related]
14. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
[TBL] [Abstract][Full Text] [Related]
15. Gliosarcoma: a clinical study.
Lutterbach J; Guttenberger R; Pagenstecher A
Radiother Oncol; 2001 Oct; 61(1):57-64. PubMed ID: 11578729
[TBL] [Abstract][Full Text] [Related]
16. Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma.
Deb P; Sharma MC; Chander B; Mahapatra AK; Sarkar C
Childs Nerv Syst; 2006 Mar; 22(3):314-9. PubMed ID: 16133270
[TBL] [Abstract][Full Text] [Related]
17. Gliosarcoma: a rare variant of glioblastoma multiforme.
Rizvi S; Asghar AH; Mehboob J
J Pak Med Assoc; 2010 Sep; 60(9):773-5. PubMed ID: 21381591
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
19. Extra-CNS metastasis from glioblastoma: a rare clinical entity.
Awan M; Liu S; Sahgal A; Das S; Chao ST; Chang EL; Knisely JP; Redmond K; Sohn JW; Machtay M; Sloan AE; Mansur DB; Rogers LR; Lo SS
Expert Rev Anticancer Ther; 2015 May; 15(5):545-52. PubMed ID: 25907706
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab.
Zhong J; Ali AN; Voloschin AD; Liu Y; Curran WJ; Crocker IR; Shu HK
Cancer; 2015 May; 121(9):1456-62. PubMed ID: 25557543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
